WIV Signed Strategic Partnership Agreement with China National Biotech Group Wuhan Company

Date:29-11-2012   |   【Print】 【close

 

Mr. Chen Xinwen and Mr. Wei Shuyuan signed on the strategic partnership agreement on behalf of their own organization and respectively introduced the current situation of and vision for the development of both sides. The two sides agreed that the signing of the strategic partnership agreement will help to facilitate the bilateral technology communication and collaborative innovation and help to display their respective advantages, promote the establishment of integrated production, teaching and research system oriented on the companies’ needs, accelerate the commercialization of technological achievements and industrialization of high technologies and elevate the scientific innovative ability of both sides. According to the strategic partnership agreement, both sides will conduct deep communication and cooperation in several areas such as development of new products, co-building of technological innovation platform and talents cultivation and exchange, etc.

Recently, WIV of Chinese Academy of Sciences signed strategic partnership agreement with China National Biotech Group Wuhan Company (i.e. Wuhan Institution of Biological Products Co., Ltd.) in Wuhan Institution of Biological Products. General Manager Mr. Wei Shuyuan, Secretary of the Party Committee Zhou Guangrong and leadership members of China National Biotech Group Wuhan Company, WIV President Mr. Chen Xinwen, Vice President Tang Hong, Science and Technology Cooperation Office of Wuhan Branch of Chinese Academy of Sciences and some middle-level cadres and experts of both sides attended the signing ceremony.